Mosaic ImmunoEngineering (OTCMKTS:CPMV) Stock Price Down 46.8%

Shares of Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMVGet Free Report) fell 46.8% during mid-day trading on Monday . The company traded as low as $0.31 and last traded at $0.31. 1,399 shares were traded during mid-day trading, an increase of 18% from the average session volume of 1,183 shares. The stock had previously closed at $0.59.

Mosaic ImmunoEngineering Trading Down 46.8 %

The business has a fifty day simple moving average of $0.56 and a 200 day simple moving average of $0.56.

Mosaic ImmunoEngineering Company Profile

(Get Free Report)

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.

See Also

Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.